Azaindoles as Janus kinase inhibitors
The instant invention provides compounds of formula I which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
Merck Sharp & Dohme Corp.
C C A
C07D C07D A61P
inventional inventional inventional
Alexey John Joon Philip John W. Christopher David Raksha June Sean P.
Rivkin Hendrix Jung Jones Butcher Dinsmore Witter Archarya Kim Ahearn